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Background: The new Earlobe Arterialized Blood Collector (EABC®) is a minimally invasive prototype system able to
perform capillary blood collection from the earlobe (EL) with minimal training and risk. This system could improve
medical emergency management in extreme environments. Consequently, a prospective validation study was
designed to evaluate operational performance of the EABC® in a cohort of critically ill patients.
Methods: Arterialized capillary blood was sampled from the EL of 55 invasively ventilated patients using the EABC®
following a validated procedure. Operational characteristics such as the number of cuts and cartridges required,
sampling failure/success ratio, bleeding complications, storage requirements and other auxiliary aspects were
recorded. Result turnaround laboratory times (TAT) were compared with published references.
Results: Blood collection was as easily performed on one earlobe as the other. Twenty-six minutes (mean 25.8;
SD = 3.8) were required to obtain results, 15 min for patient preparation (mean 15.3; SD = 2.6) + 11 min for sampling
and analysis (mean 11.4; SD = 2.1), which is similar to published hospital reference laboratory TAT. The average
number of cartridges required was 1.3 (1–3; mode = 1) with the mean number of cut attempts being 1.2 (1–4;
mode = 1). Problems/difficulties occurred in 59% of cases but were mainly attributed to patient’s demographic
characteristics, with only 10% attributable to the collector (superficial cut, blood leak, collector misalignment and
obstructed vision). Haemostasis was quickly achieved with minimum complications. Storage of the complete
sampling kit required a 300 × 300 × 300 mm box. Two 9-V batteries were used during the 2-year study period.
Conclusions: The new EABC® system concept is safe, fast and easy to use. Observed problems/difficulties are easily
amendable with certain design modifications. Definitive versions of the prototype have the potential for significant
benefits for isolated and extreme environments in medicine.
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Critical medical situations are likely to occur during
space missions in the future [1]. In such situations,
blood analysis capabilities, and especially arterial blood
gasometrical evaluation, will be essential for proper
medical management. Earlobe arterialized capillary
blood gas analysis has been proposed as an adequate
substitute for some arterial measures. This technique is
based on achieving a capillary arterio-venous shunt in* Correspondence: svaquer@tauli.cat
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unless otherwise stated.the earlobe so that capillary blood gas content approxi-
mates arterial levels [2]. Nevertheless, discordant results
are found in the literature on the accuracy of this tech-
nique, which has been extensively evaluated in healthy
volunteers during exercise [3,4], in patients with dif-
ferent forms of respiratory failure [5-9], in patients
under mechanical ventilation [10] and more recently in
a meta-analysis [11].
Performance of a new prototype system for estimating ar-
terial gas content from earlobe capillary arterialized blood,
the Earlobe Arterialized Blood Collector (EABC®) + i-STAT®
portable gas analyser, has been evaluated in healthy volun-
teers during head venous congestion, hypoxia and micro-
gravity [12,13] and in patients with chronic renal failure [14].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and enables standardization of sampling procedures. Re-
sults show good concordance of measures with arterial
samples and much better safety profile, training require-
ments and patient tolerance than arterial sampling. It has
not, however, been tested in critically ill patients. There-
fore, a validation study was designed to evaluate its ana-
lytical performance and its operational requirements in a
cohort of critically ill patients admitted to a general inten-
sive care unit (ICU) for various conditions. Results from
the analytical performance evaluation evidenced that the
EABC® + i-STAT® is precise, capable of detecting extreme
gasometric values in critically ill patients and could permit
diagnosis and classification of patients presenting with
acute respiratory distress syndrome (ARDS) [15]. We
present hereafter the operational evaluation of this equip-
ment in the routine healthcare of critically ill patients.
Methods
Operational performance of the EABC® (Microgravity
Centre/FENG-PUCRS, Brazil) + i-STAT® portable ana-
lyser (Abbot, United States of America) was evaluated in
a cohort of adult patients admitted to a general ICU.
Common demographic and clinical variables of study
patients were recorded.
Two operators were trained on the technique and per-
formed all evaluations. Training consisted of two sepa-
rated workshops in which the producer presented the
device and main procedures. Additional reference mate-
rial and remote support were available as required after
the practical sessions.
Informed consent by the patient or next of kin was re-
quired and local ethics committee accepted the study
protocol (IRB: 2009593. Comité Ètic d’Investigació Clínica,
Corporació Sanitària Universitària Parc Taulí, Sabadell,
Spain).
The sampling procedure consisted of three phases:
preparatory, blood collection or sampling and post-
sampling processes. Problems and difficulties observed
during each phase were recorded. The time expenditure
from decision to sample to the completion of post-
sampling procedures was measured (turnaround time
(TAT)). Other auxiliary aspects, such as calibration,
power consumption, software update and storage re-
quirements were also taken into account. The prepara-
tory phase consisted of analyser initialization, sampling
equipment preparation, local area setup, assessment of
patient readiness for sampling, earlobe selection, cleaning/
disinfection and capillary arterialization. Vasodilation
cream (2% nitro-glycerine cream) and earlobe massage
were used for achieving capillary arterialization. In the
blood collection phase, a blood sample was collected an-
aerobically (i.e. without contact with air) using the EABC®
(Figure 1). The collector performed a minor cut on theearlobe and aligned the blood sample with an electronic
analysis cartridge which was subsequently read by the
i-STAT® portable analyser. This device has already been
used in conjunction with the EABC® in previous validation
studies due to its appropriate performance advantages,
such as accuracy, precision, portability and rapidness of
results [16,12]. The results were displayed on the analyser
screen and were stored in its internal memory. This infor-
mation can be printed or synchronized with a computer if
required. The number of cuts and cartridges required for
obtaining a valid sample, and the overall sampling failure/
success ratio, were recorded. Post-sampling procedures
comprised achievement of haemostasis, earlobe cleaning,
shutdown of equipment, storage and addressing delayed
complications. Since the final version of the EABC® was
intended to be totally disposable, time and problems ob-
served during prototype assembly and sterilization after
use are not presented in the current evaluation but were
reported to the producer for design optimization. Patients
were grouped chronologically and the sampling failure/
success ratio was analysed in order to evaluate the lear-
ning curve of the procedure.
Data were analysed using SPSS version 19 statistical
software (International Business Machines. Armonk, New
York. United States of America) and is presented as com-
mon statistical parameters (ratio, percentage, mean, mode
and SD). Chi-Square test was used for evaluating qualita-
tive variables. Two-tailed significance threshold was estab-
lished at p < 0.05 for all statistical tests, and the 95%
confidence interval is provided where available.
Results
During this study, 55 capillary blood collections were
performed on 55 critically ill patients and the results
were evaluated. A brief summary of patient characteris-
tics can be found in Table 1.
The mean total time from decision to sample to re-
sults was 26 min (mean 25.8; SD = 3.8). Fifteen minutes
(mean 15.3; SD = 2.6) were required for the preparatory
phase and 11 min (mean 11.4; SD = 2.1) for blood col-
lection and post-sampling procedures. The i-STAT® port-
able analyser required one automated calibration per
sampling day which required 2–3 min.
Samples of earlobe (EL) capillary blood were ob-
tained in 56.4% of the cases. Sampling problems at-
tributed to the blood collector included insufficient
depth of cut (9%), blood leak, collector misalignment
and investigator-obstructed vision. Other problems not
attributed to the collector such as low-blood flow from
the EL incision and blood coagulation before reaching
the cartridge were observed in 78.1% and 9% of the
cases, respectively (Figure 2). Whenever blood collection
was achieved, it was performed as easily on one EL as
the other.
Figure 1 The Earlobe Arterialized Blood Collector (EABC®).
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ally as a rolling figure throughout the study. Results in-
dicate that 35 sampling attempts may be required before
the ratio stabilizes; however, an examination of patient
characteristics in relation to this ratio showed that older
patient clusters were associated with less favourable suc-
cess/failure ratios. The effect of age in sample success
could be observed when this ratio was analysed in diffe-
rent age groups (Figure 3), e.g. patients <50 years (n = 9)
exhibited a sampling success of 90%. Additionally, the
rather slow-inclusion rate meant that experience was
slowly gained, which could have affected the observed
learning curve.EL arterialization with vasodilation cream and EL mas-
sage was performed during 2.5 min for the first 20 pa-
tients but was later increased to 5 min for the remaining
35 patients of the study. Earlobe blood congestion was
achieved in both cases. Increasing arterialization time
did not affect sampling success rate (OR = 0.86; p = 0.8;
CI 95% = 0.28–2.67).
The average number cartridges required to obtain a
measure was 1.3 (range = 1–3; mode = 1) and associated
with a mean of 1.3 cut attempts (range = 1–4; mode = 1).
Haemostasis was easily achieved with short-bleeding times
(92.7% < 10 min) without complications (one case of sus-
pected infection that quickly resolved spontaneously).




Arterial hypertension 23 (41.8%)
Diabetes mellitus 19 (34.5%)
Chronic cardiac failure 4 (7.3%)
Severe vasculopathy 4 (7.3%)
Renal insufficiency 5 (9.1%)
Diagnostic at ICU admission
Severe sepsis 21 (38.1%)
Respiratory failure 7 (12.7%)
Severe trauma 7 (12.7%)
Neurological 6 (10.8%)
Cardiogenic shock 5 (9.1%)
Miscellaneous 9 (16%)
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contact with patient’s blood were reported.
Auxiliary procedures for the i-STAT® portable analyser
are described hereafter. Power consumption was low re-
quiring one battery change (2 × 9-V battery) during the
2-year period of the study. Regular software updates
were undertaken as required by the manufacturer. No
additional auxiliary i-STAT® equipment was required for
this study. Details on other i-STAT® technical specifica-
tions and performance characteristics can be found in
the producer manual and are available online [16].
Storage space required for the i-STAT® portable analyser,
automatic calibration system, computer-synchronization
device, ten units of the EABC® and additional material forFigure 2 Sampling failure and its causes.ten blood collections (sterile gloves, cleaning gauzes, etc.)
fitted into a 300 × 300 × 300 mm box.
Cartridge shelf life if stored at room temperature (18°C–
30°C) was 2 months; however, storage at 8°C increased
lifetime until stipulated expiration date (minimum of
6 months).
Discussion
The results from the present operational evaluation
demonstrate that the EABC® + i-STAT® system concept
is safe, fast and easy to use. The observed problems/
difficulties attributable to the collector accounted for
10% of the cases and comprised of superficial cut, blood
leak, collector misalignment and operator’s obstructed
vision. These would be easily amendable with certain de-
sign modifications.
The results from the analytical performance evaluation
have been published elsewhere [15] and showed good
precision levels (coefficient of variation < 10% in all
gasometrical variables) and enough accuracy to detect
extreme gasometrical alterations of the EABC® + i-STAT®
system (percentage of error < 20% in all gasometrical var-
iables) when compared with direct arterial reference sam-
ples. This new system was also able to correctly classify
ARDS patients according to severity (sensitivity = 100%,
specificity = 92.3%, kappa coefficient = 0.85) [15]. There-
fore, the new technique was considered useful in the initial
diagnosis and treatment of medical emergencies and could
prove to be valuable if implemented in a medical protocol
as a first evaluation tool of critically ill patients in remote
environments. From an operational point of view, a limited
sampling success rate was observed. The main causes of
sampling failure were low-blood flow from the earlobe and
blood coagulation, which had not been evidenced in
Figure 3 Sampling success according to patient age.
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system [14,12,13] or when other capillary blood collection
methods were used [3-10]. A separate evaluation was per-
formed to ascertain what factors could influence earlobe
capillary blood flow and affect sampling procedure, results
of which have been published elsewhere [15]. Using a
multivariate analysis, which took into consideration sev-
eral patient demographics and medical characteristics, the
results evidenced that patient age was the only variable as-
sociated with sampling failure. It was hypothesized that
microvascular ageing of the earlobe capillary bed could
have influenced blood flow and blood delivery to the
cartridge, leading to the observed low-sampling success
ratio in older patients [15]. Nevertheless, success rate
was 90% in patients <50 years (n = 9) and 100% in 40-
year-old patients (n = 4), which would support the use
of the EABC® + i-STAT® system in a wide range of pa-
tients, especially those in isolated and extreme environ-
ments, such as astronauts in space [17] or explorers of
remote locations on Earth.
The training required for learning the procedure of
earlobe arterialized capillary blood sampling with the
new EABC® + i-STAT® system was short, requiring only
two workshops. Although a learning curve may exist, its
interpretation was difficult and unreliable due to clus-
tered patient distribution and was not used to determine
training needs of the procedure. The two operators in-
volved in the study reported that the sampling proce-
dures were easy to perform in either of the patient’s
earlobes. Furthermore, the system was found to be port-
able, manageable and efficient, requiring a reduced num-
ber of cuts and analysis cartridges in most of the cases.
These findings confirm that the new system is easy to
use and requires minimum training as reported in pre-
vious studies.
TAT is a key determinant of laboratory performance
evaluation from an operational point of view [18]. In the
present study, a practical approach was chosen and
TATs were calculated from the decision to sample untilthe finalization of post-sampling procedures. This esti-
mation of TAT was considered to be the best interpret-
ation and information of the real operational needs of
the technique. Results showed that TAT of the whole
procedure was 26 min, lying below current TATs of
most tertiary hospitals [18]. These results were con-
sidered adequate given the specific characteristics of the
medical situations where the procedure could be used.
However, since TAT calculation can be controversial
sometimes [18], direct analysis time (or isolated laboratory
TAT) can be evaluated. In this context, if preparatory pro-
cedures are excluded, results from blood gas analysis can
be quickly obtained in 120 s using the i-STAT® portable
analyser, which still represents an appropriate time to re-
sults [16]. Furthermore, since earlobe arterialization was
achieved in spite of increases in vasodilation time, further
decrease in time expenditure for the whole procedure can
be envisaged and could lead to a theoretical reduction of
TAT to 23.5 min. Additionally, auxiliary procedures were
found to require minimum time expenditure.
This study also confirmed the safety of the new system
for both the patient and the operator. There was only
one case of suspected infection of the EL, which resolved
spontaneously. No episodes of accidental injury with the
cutting blade or contamination of the operator with pa-
tient’s blood occurred. The safe use of the device was
possible due to the containment of both blood and blade
within the collector during operation. These findings are
in agreement with previous studies in which no compli-
cations were reported.
The equipment utilized for providing autonomous
gasometrical analysis capabilities was found to require a
small storage volume. Furthermore, although the shelf life
of a refrigerated cartridge can be extended to several
months, room temperature storage during a maximum of
2 months is also possible. These findings make this new
system very suitable for environments with limited storage
capabilities such as the International Space Station and
other space systems, as well as in extreme and isolated en-
vironments on Earth.
The present study has a number of limitations. First, the
evaluation of the usability of the proposed new technique
and collector comes substantially from the subjective
opinion of operators, which could induce a bias in the
evaluation. However, both operators were able to learn the
procedure quickly and required only one cut to obtain a
valid blood sample in most of the cases, which supports
that sufficient skills on the use of the technique had been
achieved. Second, as previously discussed, the presence of
a learning curve may suggest that 35 sampling attempts
are required to learn the procedure. However, unbalanced
distribution of patients makes this assessment unreliable.
There must be a minimum number of test rounds re-
quired; however, data are insufficient to determine such a
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critically ill patients in the controlled environment of an
ICU. While the use of a varied population of such patients
may provide useful information that could be transferrable
to other similar patients in extreme or remote environ-
ments, other uncontrolled factors such as temperature,
humidity or atmospheric pressure may influence perfor-
mance and operational characteristics of the technique.
Therefore, additional field studies are required to confirm
the potential benefits for patient healthcare in remote en-
vironments suggested in the present analysis.
Conclusions
In conclusion, this evaluation has demonstrated that op-
erational characteristics of the new EABC® + i-STAT®
system such as efficiency, sampling performance in spe-
cific patients, usability, minimum training requirements
and reduced time to results, make it very suitable for use
in remote and isolated environments such as space. Good
accuracy and diagnostic capabilities in combination with
abovementioned operational features suggest that defini-
tive versions of the prototype can offer significant benefits
for patient health care in space and other extreme envi-
ronments. Future studies should focus on confirming the
benefits of use of this new equipment and technique in
such medical scenarios.
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